We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

A young woman with pulmonary embolism, myocarditis and fungal endocarditis after COVID-19 infection: a case report

    Mehran Lak

    Critical Care Quality Improvement Research Center, Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    ,
    Sepideh Jafari Naeini

    *Author for correspondence: Tel.: +98 212 3515;

    E-mail Address: sepidehjafari@sbmu.ac.ir

    Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    ,
    Alireza Omidi Farzin

    Department of Cardiovascular Surgery, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    ,
    Manoochehr Hekmat

    Department of Cardiovascular Surgery, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    &
    Atoosa Gharib

    Pathology Department, Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Published Online:https://doi.org/10.2217/fca-2023-0036

    A young woman with a history of COVID-19 infection and concomitant visual problems was admitted with exacerbation of dyspnea. Upon admission, pulmonary embolism, myocarditis and fungal endocarditis were detected, probably due to persistent underlying inflammation. She underwent surgical replacement of the tricuspid valve and antifungal treatment.

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1. Maamar M, Artime A, Pariente E et al. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study. Curr. Med. Res. Opin. 38(6), 901–909 (2022).
    • 2. SeyedAlinaghi S, Afsahi AM, MohsseniPour M et al. Late complications of COVID-19: a systematic review of current evidence. Arch. Acad. Emerg. Med. 9(1), e14 (2021).
    • 3. Lopez-Leon S, Wegman-Ostrosky T, Perelman C et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci. Rep. 11(1), 16144 (2021). •• A systematic review and meta-analysis about the persistent, long term or ongoing symptoms and manifestations from 14 to 110 days post-COVID-19 infection. Most prevalent one, has been fatigue and headache based on this report.
    • 4. Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am. J. Physiol. Cell Physiol. 322(1), C1–C11 (2021).
    • 5. Desgranges F, Tadini E, Munting A et al. Post–COVID–19 syndrome in outpatients: a cohort study. J. Gen. Int. Med. 37(8), 1943–1952 (2022).
    • 6. Nasiri N, Sharifi H, Bazrafshan A, Noori A, Karamouzian M, Sharifi A. Ocular manifestations of COVID-19: a systematic review and meta-analysis. J. Ophthalmic Vis. Res. 16(1), 103–112 (2021).
    • 7. Bolletta E, Iannetta D, Mastrofilippo V et al. Uveitis and other ocular complications following COVID-19 vaccination. J. Clin. Med. 10(24), 5960 (2021).
    • 8. (United TAMC, Kingdom) MMCI, Marianna Adamo (Task Force, Coordinator) (Italy) RSGTFCUK. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 1, 1–128 (2021).
    • 9. Nazari T, Sadeghi F, Izadi A, Sameni S, Mahmoudi S. COVID-19-associated fungal infections in Iran: a systematic review. PLOS ONE 17(7), e0271333 (2022). • A systematic review with English and Persian research about fungal infections as a complication of COVID-19.
    • 10. Pemán J, Ruiz-Gaitán A, García-Vidal C et al. Fungal co-infection in COVID-19 patients: should we be concerned? Rev. Iberoam. Micol. 37(2), 41–46 (2020).
    • 11. Siripanthong B, Nazarian S, Muser D et al. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm 17(9), 1463–1471 (2020).
    • 12. Chiappetta S, Sharma AM, Bottino V, Stier C. COVID-19 and the role of chronic inflammation in patients with obesity. Int. J. Obes. 44(8), 1790–1792 (2020).
    • 13. Lawrensia S, Henrina J, Cahyadi A. Multisystem inflammatory syndrome in adults: a systematic review and meta-analysis of the rheumatological spectrum of complications post COVID-19 infection. Rev. Colomb. Reumatol. 29(1), S17–S24 (2021).
    • 14. Bajaj R, Sinclair HC, Patel K et al. Delayed-onset myocarditis following COVID-19. Lancet Respir. Med. 9(4), e32–e34 (2021).
    • 15. Yousaf AR, Cortese MM, Taylor AW et al. Reported cases of multisystem inflammatory syndrome in children aged 12–20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation. Lancet Child. Adolesc. Health 6(5), 303–312 (2022).
    • 16. Gluckman TJ, Bhave NM, Allen LA et al. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. 79(17), 1717–1756 (2022). •• A valuable expert consensus about the myocardial involvement during or after COVID-19 infection.
    • 17. Boudhabhay I, Rabant M, Roumenina LT et al. Case report: adult post-COVID-19 multisystem inflammatory syndrome and thrombotic microangiopathy. Front. Immunol. 12, 680567 (2021).